A government report shows how dozens of drugs that received a special “accelerated” approval have no proof of actual clinical benefit to patients. Action Alert! Taxpayers are spending billions on drugs that have little or no data to support their efficacy. This is the bombshell finding of a report from the Office of Inspector General (OIG) on the failings of the FDA’s accelerated drug approval program. Read more.
Get Informed on Issues Related to Drugs
Most Dementia is Driven by Diet, not Genes
In the days of Hippocrates, diseases were blamed on the gods. He didn’t buy that and explored the causes of disease saying ‘let food be thy medicine’. Nowadays a lot of diseases are being blamed on genes — because knowledge about genes and their effects has advanced tremendously over the last several decades. Genes are the code, or instructions, to assemble proteins, for example to make an enzyme, a hormone or a biochemical such as cholesterol or phospholipids. Read more.
Do You Want to Die Old or Sick?
We are somewhat indoctrinated by prior generations to eventually expect to spend a few years in the old folks’ home being sick, but how avoidable is that? The associated question I carry around is, “Why save for retirement if all you are going to do is spend it on doctors and hospitals?” Isn’t health the first wealth? Read more.
What They got Wrong about Covid
For as long as I can remember, over a 40 year career in medicine, there have existed two warring paradigms about disease: One envisions a future in which science will ultimately vanquish all disorders with ever more precisely-targeted drug and surgical interventions; the other maintains that the truth path to wellness lies in harnessing diet, lifestyle and nontoxic natural modalities to offer prevention and cures. Read more.
FDA is Failing Women
Women coping with menopause have been ignored by mainstream medicine for years, and now the FDA is making it worse by threatening to ban estriol and other medicines that can support women’s health. Action Alert! Read more.
FDA Gives Accelerated Approval for Risky Alzheimer’s Pill
The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi). The drug, a monoclonal antibody, binds to amyloid beta in the brain. An 18-month study published in the New England Journal of Medicine found Leqembi reduced markers of amyloid in early Alzheimer’s disease and led to “moderately less decline” in cognition and function compared to placebo. However, the study added, the drug was “associated with adverse events.” Read more.
Big Pharma’s Influence in Shaping the U.S. Medical Model
The United States is the most medicated country in the world, with 70 percent of Americans using at least one prescription drug daily. The U.S. also has the highest rates of obesity, heart disease, childhood illness, and autoimmune disease, yet it often touts its health care and medical research as the best in the world. Read more.
My Journey out of a Grim Diagnosis
I am a male 65 year old healthcare professional who was diagnosed with stage four colon cancer, in December 2021 and had a tumor removed from my transverse colon on December 30, 2021. The cancer had metastasized to my lymph nodes, my liver and my lung. Approximately eight weeks after surgery, I started traditional chemotherapy and intravenous vitamin C. On my first visit with the oncologist, she informed me that my prognosis was grim and that I had approximately a two year survival rate. Read more.
Common Medications that Increase Blood Pressure (video)
Evidence Based Medicine Takes a New Turn
Distinguished members, our decades of disparaging nutritional therapy have paid off at last. The public, and their healthcare providers, are completely hoodwinked. By pushing “evidence based medicine” on the medical professions, we have elegantly slipped in our choice of evidence to base medicine on. And this is no mere journeyman accomplishment: this is high art. Mr. Machiavelli would be pleased. Certainly the pharmaceutical cartel is. We are well on our way to eliminating the competition, namely that increasingly irritating “orthomolecular medicine” faction. Read more.